This feature covers the "Treatment Strategies and Clinical Evidence for Checkpoint Inhibiton" section of the current Evolving Paradigms in Immuno-Oncology issue.
Novel Approaches Focus on Limiting Toxicity in Older Patients With ALL
April 22nd 2024The major challenges for clinicians treating older patients with acute lymphoblastic leukemia surround the emergence of resistance to existing therapies and the toxicities associated with current chemotherapies.
Read More